Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$218,568
-$19,475 QoQ
Shares Held
1,730
+1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,873
of 2,266 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLCM Advisors, Inc. holds $30,076,760 across 9 Drug Manufacturers - General names. GILD ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
293,739 | $16,925,241 | |
| 2 | PFE |
Pfizer Inc
|
166,401 | $4,006,936 | |
| 3 | ABBV |
AbbVie Inc.
|
10,009 | $2,518,664 | |
| 4 | JNJ |
Johnson & Johnson
|
8,607 | $2,185,919 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,218 | $1,698,513 | |
| 6 | LLY |
ELI LILLY & Co
|
1,147 | $1,375,746 | |
| 7 | OGN |
Organon & Co.
|
48,807 | $660,846 | |
| 8 | AMGN |
Amgen Inc
|
1,343 | $486,327 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218,568 | 1,730 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $238,043 | 1,708 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $209,639 | 1,708 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $206,238 | 1,858 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $200,452 | 1,808 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $202,586 | 1,808 | Shares | Sole | 2025-05-13 | |
| 2024-06-30 | $2,483,887 | 36,203 | Shares | Sole | 2024-08-14 | |
| 2022-09-30 | $2,914,235 | 47,240 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,808,522 | 45,438 | Shares | Sole | 2022-08-04 | |
| No filing history on record for this holder in this stock. | ||||||